Surface chemistry of carbon nanoparticles functionally select their uptake in various stages of cancer cells
- 6 May 2017
- journal article
- research article
- Published by Tsinghua University Press in Nano Research
- Vol. 10 (10) , 3269-3284
Abstract
Relationship of the surface physicochemical characteristics of nanoparticles with their interactions with biological entities may provide critical information for nanomedicinal application. Here, we report the systematic synthesis of sub-50 nm carbon nanoparticles (CNP) presenting neutral, anionic, and cationic surface functionalities. A subset of CNPs with ~10, 20, and 40 nm hydrodynamic sizes were synthesized with neutral surface headgroups. For the first time, the cellular internalization of these CNPs was systematically quantified in various stages of breast cancer cells (early, late, and metastatic), thereby providing a parametric assessment of charge and size effects. Distinct activities were observed when these systems interacted with cancer cells in various stages. Our results indicated that metastatic breast cancer could be targeted by a nanosystem presenting anionic phosphate groups. On the contrary, for patients in late stage of cancer, drugs could be delivered with sulfonate functionalized carbon nanoparticles, which have higher probability of intracellular transport. This study will facilitate the better understanding of nanoparticle–biological entity interaction, and the integration of this knowledge with pathophysiology would promote the engineering of nanomedicine with superior likelihoods of crossing the endocytic “barrier” for drug delivery inside cancerous cells.Keywords
This publication has 42 references indexed in Scilit:
- Nanoparticles in the clinicBioengineering & Translational Medicine, 2016
- Internalization pathways of nanoparticles and their interaction with a vesicleSoft Matter, 2013
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2012
- Cellular Uptake of Nanoparticles by Membrane Penetration: A Study Combining Confocal Microscopy with FTIR SpectroelectrochemistryACS Nano, 2012
- Nanoparticle Therapeutics: FDA Approval, Clinical Trials, Regulatory Pathways, and Case Study2011
- The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and PitfallsMolecular Therapy, 2010
- Mechanisms of EndocytosisAnnual Review of Biochemistry, 2009
- Impact of Nanotechnology on Drug DeliveryACS Nano, 2009
- Impact of Nanoscience and Nanotechnology on Controlled Drug DeliveryNanomedicine, 2008
- Cancer nanotechnology: opportunities and challengesNature Reviews Cancer, 2005